TB Notes Newsletter
No. 1, 2007
New CDC Publications
Aziz MA, Wright A, Laszlo A, De Muynck A,
Portaels F, Van Deun A, Wells C, Nunn P, Blanc L, and Raviglione M. Epidemiology
of antituberculosis drug resistance (the Global Project on Anti-Tuberculosis
Drug Resistance Surveillance): an updated analysis. Lancet 2006
Dec 16; 368 (9553): 2142-54.
CDC. Brief report: latent
tuberculosis infection among sailors and civilians aboard U.S.S. Ronald Reagan
--- United States,
January–July 2006. MMWR 2006; 55: 1381-82.
CDC. Emergence of Mycobacterium tuberculosis
with extensive resistance to second-line drugs - worldwide, 2000–2004.MMWR.
2006; 55(11): 301-305.
CDC. Revised definition of extensively drug-resistant
tuberculosis. [Notice to readers]. MMWR 2006; 55(43): 1176.
Cain KP, Haley CA, Armstrong LR, Garman KN, Wells CD, Iademarco MF, Castro
KG, Laserson KF. Tuberculosis among foreign-born persons in the United
States: achieving tuberculosis elimination. Am J Respir
Crit Care Med 2007; 175: 75-79.
Rich ML, Cegielski JP, Jaramillo E, Lambregts
van Weezenbeek C (Eds-in-Chief). Guidelines for the programmatic management
of drug-resistant tuberculosis. Geneva:
World Health Organization, 2006. (WHO/HTM/TB/2006.361).
Shah NS, Wright A, Bai G-H, Barrera L, Boulahbal F, Martín-Casabona N, et al.
Worldwide emergence of
extensively drug-resistant tuberculosis. Emerg Infect Dis [serial on the
Internet]. 2007 Mar [date cited]. |
